Recent Updates
Recently added Catalysts
QNRX Positive Sentiment Score: 70/100

Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025

Thursday, July 31, 2025 1 min read
Key Takeaway: Quoin Pharmaceuticals has announced the release date for its second quarter 2025 financial results, which will be disclosed on August 7, 2025. The report is expected to include an operational update detailing key achievements and financial highlights for the quarter ending June 30, 2025. The company specializes in developing treatments for rare and orphan diseases, with a focus on unmet medical needs.

Market Sentiment Analysis

POSITIVE FACTORS

  • Quoin Pharmaceuticals is focusing on rare and orphan diseases.
  • The upcoming financial results will include operational and financial highlights.
  • Quoin has a diverse pipeline targeting multiple rare conditions.

Full Press Release Details

ASHBURN, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its financial results for the second quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025.
The announcement will include an operational update highlighting key achievements from the quarter, recent accomplishments, and financial highlights.
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, go to: www.quoinpharma.com.
For further information, contact:
Quoin Pharmaceuticals Ltd.
Michael Myers, Ph.D., CEO
mmyers@quoinpharma.com
jramson@pcgadvisory.com

Frequently Asked Questions

When will Quoin Pharmaceuticals release its Q2 financial results?

Quoin Pharmaceuticals will release its Q2 financial results on August 7, 2025.

What will be included in Quoin's upcoming announcement?

The announcement will feature an operational update and financial highlights.

What is the focus of Quoin Pharmaceuticals Ltd.?

Quoin Pharmaceuticals focuses on developing therapies for rare and orphan diseases.

How many products are in Quoin's development pipeline?

Quoin has four products in development targeting various rare diseases.

What types of diseases does Quoin target with its products?

Quoin targets diseases like Netherton Syndrome and Epidermolysis Bullosa.

Tags: QNRX Viatris Investor Conferences Healthcare Quoin Pharmaceuticals rare diseases financial results orphan diseases
Last updated: Jul 31, 2025